C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma.
Saved in:
| Title: | C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma. |
|---|---|
| Authors: | Pang C; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China.; Hebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, Hebei, People's Republic of China., Chen J; Digestive System Department, Affiliated Hospital of Chengde Medical University, Chengde Medical University, Chengde, Hebei, People's Republic of China., Chu M; Institute of Sericulture, Chengde Medical University, Chengde, Hebei, People's Republic of China., Chen J; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China., Wang H; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China., Miao H; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China. |
| Source: | Journal of hepatocellular carcinoma [J Hepatocell Carcinoma] 2026 Apr 13; Vol. 13, pp. 587037. Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Country of Publication: New Zealand NLM ID: 101674775 Publication Model: eCollection Cited Medium: Print ISSN: 2253-5969 (Print) Linking ISSN: 22535969 NLM ISO Abbreviation: J Hepatocell Carcinoma Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2253-5969 |
|---|---|
| DOI: | 10.2147/JHC.S587037 |
